Literature DB >> 21933225

Multivessel versus single vessel spasm, as assessed by the intracoronary acetylcholine provocation test, in Korean patients.

Ji Young Park1, Seung-Woon Rha, Zhe Jin, Kanhaiya L Poddar, Sureshkumar Ramasamy, Kang-Yin Chen, Yong-Jian Li, Byoung Geol Choi, Sung Kee Ryu, Jae Woong Choi, Eun Ju Song, Ji Won Ryou, Amro Elnagar, Yun Kyung Kim, Jin Oh Na, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh.   

Abstract

1. Coronary artery spasm (CAS) is known to be a major cause of myocardial ischaemia. Multivessel coronary spasm (MVS) in particular is likely to induce more severe and prolonged myocardial ischaemia than single vessel spasm (SVS). 2. In the present study, a total of 1082 consecutive patients without significant coronary artery disease who underwent an acetylcholine (ACh) provocation test between March 2004 and April 2009 were investigated. Patients were divided into three groups: an MVS group (n = 275), an SVS group (n = 376) and a non-CAS group (n = 431). Differences in clinical and angiographic characteristics following the ACh provocation test were evaluated between the MVS, SVS and non-CAS groups. 3. At baseline, patients in the MVS group had the highest prevalence of peripheral artery disease (PAD), hyperlipidaemia, smoking and old age, as well as the highest triglyceride levels. Calcium channel blockers were most frequently prescribed in MVS patients before the ACh test. During the ACh test, the highest prevalence of chest pain, ischaemic electrocardiogram changes, baseline spasms and diffuse and severe spasms were observed in the MVS group. The response rate to lower ACh doses that induce CAS was also higher in the MVS group. Multivariate analysis showed that the presence of PAD (odds ratio (OR) 2.0; P = 0.006) and baseline spasm (OR 1.4; P = 0.045) were independent predictors of ACh-induced MVS. 4. In conclusion, ischaemic symptoms, diffuse and severe spasm and baseline spasm were more frequently associated with MVS patients, suggesting more intensive medical therapies and close clinical follow up would be required for this patient group.
© 2011 The Authors. Clinical and Experimental Pharmacology and Physiology © 2011 Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21933225     DOI: 10.1111/j.1440-1681.2011.05611.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  3 in total

1.  Impact of Diltiazem Alone versus Diltiazem with Nitrate on Five-Year Clinical Outcomes in Patients with Significant Coronary Artery Spasm.

Authors:  Taeshik Park; Ji Young Park; Seung Woon Rha; Hong Seog Seo; Byoung Geol Choi; Se Yeon Choi; Jae Kyeong Byun; Sang Ho Park; Eun Jin Park; Jah Yeon Choi; Sung Hun Park; Jae Joong Lee; Sunki Lee; Jin Oh Na; Cheol Ung Choi; Hong Euy Lim; Jin Won Kim; Eung Ju Kim; Chang Gyu Park; Dong Joo Oh
Journal:  Yonsei Med J       Date:  2017-01       Impact factor: 2.759

2.  The multi-vessel and diffuse coronary spasm is a risk factor for persistent angina in patients received anti-angina medication.

Authors:  Sang-Ho Park; Byoung Geol Choi; Seung-Woon Rha; Tae Soo Kang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

3.  The impact of high sensitivity C-reactive protein level on coronary artery spasm as assessed by intracoronary acetylcholine provocation test.

Authors:  Ji Young Park; Seung-Woon Rha; Yong-Jian Li; Kang-Yin Chen; Byoung Geol Choi; Se Yeon Choi; Sung Kee Ryu; Jae Woong Choi; Tae Kyun Kim; Jeong Min Kim; Yoon Suk Bak; Jae Hoon Lee; Sung Il Im; Sun Won Kim; Jin Oh Na; Cheol Ung Choi; Hong Euy Lim; Jin Won Kim; Eung Ju Kim; Chang Gyu Park; Hong Seog Seo; Dong Joo Oh
Journal:  Yonsei Med J       Date:  2013-11       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.